直接内镜经鼻入路治疗原发性鞍区病变:404例当代病例系列的安全性与有效性
多数为垂体腺瘤(86%),无死亡,围手术期并发症发生率低,多数术前症状获临床改善。
要点
- 404例中垂体腺瘤占86%,无手术死亡,脑脊液漏4%、鼻出血4%。
- 垂体腺瘤全切除率58%,功能性腺瘤激素缓解率82%。
- 头痛和视力缺损分别有67%和76%获临床改善,中位住院2天。
核心结论
- 直接EEA治疗鞍区病变可安全有效地由神经外科团队完成,围手术期并发症发生率低且多数术前症状获改善。
主要发现
- 404例中垂体腺瘤349例(86%)、Rathke裂囊肿29例(7%)、其他鞍区病变26例(6%)。
- 病变平均直径2.3 cm,微腺瘤34例(10%)、大腺瘤315例(90%);39%的垂体腺瘤存在海绵窦侵犯。
- 无患者死亡;脑脊液漏4%、鼻出血4%、视力丧失0.7%、脑膜炎0.7%、新发垂体功能减退3%。
- 垂体腺瘤全切除208例(58%);头痛改善67%、视力缺损改善76%;功能性垂体腺瘤激素缓解82%。
- 中位住院2天,30天内再入院34例(8%),早期再手术10例(3%);复发或进展10%,全切除和卒中者更少。
临床怎么用
- 对于鞍区病变,直接EEA可作为主要手术方式,围手术期并发症发生率低且住院时间短。
- 全切除与卒中患者复发或进展风险更低,支持在安全前提下追求全切除并加强随访。
局限性
- 本文为回顾性、多数单一术者的病例系列,未设对照组,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The direct endoscopic endonasal approach (EEA) has become the primary technique used for resection of sellar pathology, meriting investigation into the risk factors for complications and predictors of postoperative outcomes after direct EEA. METHODS: We retrospectively analyzed the patient and tumor characteristics from 404 patients who had undergone direct EEA for sellar pathology at the USC Pituitary Center from September 2011 to December 2019. RESULTS: Of the 404 pathologic entities included, 349 (86%) were pituitary adenomas (PAs), 29 (7%) were Rathke cleft cysts, and 26 (6%) were other sellar lesions. The mean lesion diameter was 2.3 cm, with 34 microadenomas (10%) and 315 macroadenomas (90%). Cavernous sinus invasion was present in 39% of the PAs. No patient died. The surgical complications included internal carotid artery injury without neurological sequelae (0.2%), vision loss (0.7%), meningitis (0.7%), cerebrospinal fluid leak (4%), epistaxis (4%), sinusitis (1%), transient cranial nerve paresis (0.5%), and postoperative abscess (0.25%). New hypopituitarism developed in 3%. Gross total resection was achieved in 208 PA cases (58%). Clinical improvement of headaches and visual deficits were reported for 67% and 76% of cases, respectively. Hormonal remission was achieved in 82% of patients with functional PAs. The median hospital stay was 2 days, with 34 patients (8%) readmitted within 30 days and 10 (3%) undergoing early reoperation. Disease recurrence or progression developed in 10% and was less likely in the case of gross total resection and apoplexy. CONCLUSION: In the present, large, consecutive, mostly single-surgeon series, the patients experienced clinical improvement in most preoperative symptoms and had low rates of perioperative morbidity. We have demonstrated that direct EEA can be efficiently, safely, and successfully performed by a neurosurgical team.
引用
- Cardinal T, Brunswick A, Strickland BA, et al. Safety and Effectiveness of the Direct Endoscopic Endonasal Approach for Primary Sellar Pathology: A Contemporary Case Series of More Than 400 Patients. World Neurosurg. 2021. PMID: 33454431. doi:10.1016/j.wneu.2021.01.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。